SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-281018
Filing Date
2015-08-06
Accepted
2015-08-06 16:11:20
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d937801d10q.htm 10-Q 419699
2 EX-3.1 d937801dex31.htm EX-3.1 16178
3 EX-31.1 d937801dex311.htm EX-31.1 6741
4 EX-32.1 d937801dex321.htm EX-32.1 4456
  Complete submission text file 0001193125-15-281018.txt   1818391

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acad-20150630.xml EX-101.INS 247513
6 XBRL TAXONOMY EXTENSION SCHEMA acad-20150630.xsd EX-101.SCH 21773
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20150630_cal.xml EX-101.CAL 41193
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20150630_def.xml EX-101.DEF 54901
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20150630_lab.xml EX-101.LAB 172975
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20150630_pre.xml EX-101.PRE 118745
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 151033244
SIC: 2834 Pharmaceutical Preparations